|
Delayed
NSE India S.E.
16:40:43 02/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 874.15 INR | +0.28% |
|
+0.51% | +18.67% |
| Market Cap | 4.97B 52.33M 45.14M 42.46M 38.68M 72.74M 73.13M 502M 195M 2.53B 196M 192M 8.38B | P/E 2025 |
26.9x | P/E 2026 | -224x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69B 28.3M 24.41M 22.96M 20.92M 39.34M 39.56M 271M 106M 1.37B 106M 104M 4.53B | EV / Sales 2025 |
0.67x | EV / Sales 2026 | 0.32x |
| Free-Float |
35.96% | Yield 2025 |
0.62% | Yield 2026 | 0.85% |
| 1 day | +0.28% | ||
| 1 week | +0.51% | ||
| Current month | -2.65% | ||
| 1 month | +26.22% | ||
| 3 months | +22.18% | ||
| 6 months | +27.33% | ||
| Current year | +18.67% |
| 1 week | 861 |  | 931.85 |
| 1 month | 685.55 | | 931.85 |
| Current year | 579.9 | | 931.85 |
| 1 year | 579.9 | | 931.85 |
| 3 years | 579.9 | | 1,753.95 |
| 5 years | 486.85 | | 1,753.95 |
| 10 years | 263 | | 1,753.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amit Mahla
CEO | Chief Executive Officer | 52 | 12/05/2026 |
| Director of Finance/CFO | - | 01/12/2020 | |
Lalit Lohia
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 30/12/2009 | |
| Director/Board Member | 69 | 31/03/2014 | |
Monjori Mitra
BRD | Director/Board Member | 64 | 24/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.28% | +0.51% | - | - | 52.33M | |
| -0.05% | +1.56% | +23.25% | +73.97% | 48.77B | |
| -1.61% | -0.29% | +51.58% | +118.38% | 40.67B | |
| -1.26% | +0.30% | +15.80% | +85.90% | 12.27B | |
| -0.76% | +0.70% | -9.99% | +14.02% | 12.11B | |
| +0.57% | +1.73% | +31.59% | +153.11% | 9.28B | |
| -1.37% | -2.78% | +24.45% | +44.79% | 7.55B | |
| -0.38% | +0.96% | +28.29% | +223.26% | 7.35B | |
| -0.62% | -0.84% | +44.70% | -11.26% | 7.3B | |
| -0.13% | -0.16% | -40.47% | +15.85% | 5.25B | |
| Average | -0.52% | +1.04% | +18.80% | +79.78% | 16.73B | |
| Weighted average by Cap. | -0.68% | +1.25% | +27.26% | +86.65% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.46B 36.43M 31.43M 29.56M 26.93M 50.64M 50.92M 349M 136M 1.76B 137M 134M 5.83B | 3.34B 35.15M 30.32M 28.52M 25.98M 48.86M 49.13M 337M 131M 1.7B 132M 129M 5.63B |
| Net income | 172M 1.81M 1.56M 1.47M 1.34M 2.52M 2.53M 17.39M 6.77M 87.5M 6.8M 6.66M 290M | -14.95M -157K -136K -128K -116K -219K -220K -1.51M -588K -7.6M -591K -578K -25.21M |
| Net Debt | -2.31B -24.38M -21.03M -19.78M -18.02M -33.88M -34.07M -234M -91.01M -1.18B -91.52M -89.53M -3.9B | -2.28B -24.02M -20.72M -19.49M -17.76M -33.4M -33.58M -230M -89.7M -1.16B -90.2M -88.24M -3.85B |
Employees
1,476
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | ₹874.15 | +0.28% | 3,477 |
| 01/09/26 | ₹871.70 | -2.92% | 7,074 |
| 31/08/26 | ₹897.90 | -0.08% | 14,450 |
| 28/08/26 | ₹898.60 | +0.94% | 20,164 |
| 27/08/26 | ₹890.25 | +2.36% | 8,084 |
- Stock Market
- Stocks
- ALBERTDAVD Stock
- ALBERTDAVD Stock
Select your edition
All financial news and data tailored to specific country editions
